Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of GSK3196165 plus methotrexate in moderate-to-severe rheumatoid arthritis
2014-003453-34Phase 2Completed
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing GSK3196165 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: DAS28(CRP) remission. Started May 2015; status: completed.
02
Drugs
otilimab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2014-003453-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003453-34.